Locoregional surgery, systemic treatment, including neoadjuvant and adjuvant chemotherapy with anti-HER2 agents, endocrine therapy, and radiotherapy are all commonly employed in treating early HER2+BC. The gene discussed is ERBB2; the disease is breast cancer.